Abstract
Background and Aims : In the European-wide DA VINCI study, only 33% of patients attained their risk-based 2019 ESC/EAS guideline LDL-C goals. We aimed to simulate the impact of the step-wise implementation of the ESC/EAS lipid-lowering treatment (LLT) pathway on LDL-C goal attainment across risk categories.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
